Actinium Pharmaceuticals Inc (ATNM)
8.74
+0.96
(+12.34%)
USD |
NYAM |
May 02, 16:00
8.74
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Cash and Short Term Investments (Quarterly): 84.06M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 84.06M |
| December 31, 2023 | 76.68M |
| September 30, 2023 | 82.98M |
| June 30, 2023 | 91.28M |
| March 31, 2023 | 94.52M |
| December 31, 2022 | 108.91M |
| September 30, 2022 | 111.82M |
| June 30, 2022 | 116.33M |
| March 31, 2022 | 72.02M |
| December 31, 2021 | 77.83M |
| September 30, 2021 | 82.03M |
| June 30, 2021 | 81.91M |
| March 31, 2021 | 72.25M |
| December 31, 2020 | 63.56M |
| September 30, 2020 | 48.23M |
| June 30, 2020 | 53.47M |
| March 31, 2020 | 5.942M |
| December 31, 2019 | 9.254M |
| September 30, 2019 | 14.31M |
| June 30, 2019 | 19.52M |
| March 31, 2019 | 9.925M |
| December 31, 2018 | 13.67M |
| September 30, 2018 | 14.81M |
| June 30, 2018 | 21.47M |
| March 31, 2018 | 26.76M |
| Date | Value |
|---|---|
| December 31, 2017 | 17.40M |
| September 30, 2017 | 20.54M |
| June 30, 2017 | 11.46M |
| March 31, 2017 | 17.09M |
| December 31, 2016 | 20.52M |
| September 30, 2016 | 15.53M |
| June 30, 2016 | 20.46M |
| March 31, 2016 | 22.21M |
| December 31, 2015 | 25.64M |
| September 30, 2015 | 24.77M |
| June 30, 2015 | 25.97M |
| March 31, 2015 | 19.30M |
| December 31, 2014 | 6.718M |
| September 30, 2014 | 11.75M |
| June 30, 2014 | 14.67M |
| March 31, 2014 | 5.878M |
| December 31, 2013 | 5.539M |
| September 30, 2013 | 3.990M |
| June 30, 2013 | 5.650M |
| March 31, 2013 | 3.240M |
| December 31, 2012 | 5.619M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.0001M |
| March 31, 2012 | 0.0001M |
| December 31, 2011 | 5.704M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.942M
Minimum
Mar 2020
116.33M
Maximum
Jun 2022
68.34M
Average
77.25M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 9.238M |
| Eli Lilly and Co | 2.586B |
| Cellectar Biosciences Inc | 9.565M |
| Outlook Therapeutics Inc | 10.36M |
| Bristol-Myers Squibb Co | 9.67B |